Albumin News and Research

RSS

Study shows MPXV can persist on surfaces for extended periods, but can be inactivated by alcohol-based disinfectants

Researcher evaluates the stability of monkeypox virus (MPXV) on stainless steel surfaces stored at different temperatures and using different interfering substances to mimic environmental contamination.

7 May 2023

Small vesicles released by intestinal bacteria induce immune activation and progression of liver cirrhosis

Researchers from Niigata University and Kyoto Prefectural University have revealed that small vesicles, around 100 nm in size, released by intestinal bacteria induce immune activation and progression of liver cirrhosis, as well as reduction of serum albumin level, subsequently leading to edema and ascites.

19 Apr 2023

Study finds human surfactant protein A can inhibit SARS-CoV-2 infectivity

Researchers assess the efficacy of the human surfactant protein A against SARS-CoV-2 infectivity.

10 Apr 2023

Red blood cell hitch-hiking facilitates SARS-CoV-2 multi-organ spread

Researchers assessed the infectious capacity of severe acute respiratory syndrome coronavirus 2 in plasma and red blood cells.

3 Apr 2023

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

In a recent study published in the journal BMJ Medicine, researchers in the United Kingdom and Sweden investigated the probable causality of long-term serum caffeine concentrations on type 2 diabetes (T2D), adiposity, and major cardiovascular diseases (CVDs).

22 Mar 2023

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Albumedix Ltd, Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing.

From Albumedix Ltd. 16 Mar 2023

Researchers shine new light on a potential target for the treatment of diabetic nephropathy

The kidneys perform a critical role in the body by removing waste and excess fluid in the form of urine. In a condition known as diabetic nephropathy, complications from diabetes disrupt the ability of the kidneys to function properly.

15 Mar 2023

Novel culture system for effectively growing large numbers of blood stem cells in the lab

Hematopoietic stem cells (HSCs) are important immature blood cells in bone marrow that can be triggered to develop into any blood cell type.

8 Mar 2023

The role of caffeine in preventing diabetic retinopathy

Moderate and high caffeine intake offered protection against the development of diabetic retinopathy.

5 Mar 2023

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

In a recent study published in The New England Journal of Medicine, researchers reviewed selected acute-phase proteins concerning their production, structure, and function.

7 Feb 2023

Overweight people have a different vitamin D metabolism

A new study in JAMA Network Open aimed to determine whether BMI is capable of modifying vitamin D metabolism as well as response to supplementation.

18 Jan 2023

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

Researchers investigated the ability of kinetin (N6-furfurylaminopurine, MB-905) to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proliferation in vitro.

17 Jan 2023

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Researchers used electronic health records to characterize the incidence, biomarkers, attributes, and severity of SARS-CoV-2 reinfections and evaluated the association between reinfections and long coronavirus disease (COVID).

10 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

Albumin News and Research

Study shows MPXV can persist on surfaces for extended periods, but can be inactivated by alcohol-based disinfectants

Small vesicles released by intestinal bacteria induce immune activation and progression of liver cirrhosis

Study finds human surfactant protein A can inhibit SARS-CoV-2 infectivity

Red blood cell hitch-hiking facilitates SARS-CoV-2 multi-organ spread

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Researchers shine new light on a potential target for the treatment of diabetic nephropathy

Novel culture system for effectively growing large numbers of blood stem cells in the lab

The role of caffeine in preventing diabetic retinopathy

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

Overweight people have a different vitamin D metabolism

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

Study explores incidence, severity, and long COVID associations of SARS-CoV-2 reinfections

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

New insights into the bioavailability and hepatoxicity risk of neonicotinoids

Keeping hydrated can reduce aging and extend disease-free life

Walnut consumption may have a protective effect against academic stress in university students

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

New tool may help better predict resistance to immunoglobulin therapy among children with Kawasaki disease

What is the association between renal function and regular coffee consumption?

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News